Sorry, you need to enable JavaScript to visit this website.

Branded vs. Generic

  • Branded drugs are more expensive because they’re newer, generally groundbreaking, and often for conditions that are difficult to treat. However, after a certain period of time, these same innovative medicines become generic medicines.

  • The difference between our approach and that of many other companies is that when a medicine becomes a generic, we still assume responsibility. Rather than focus on just what’s in development, we continue to closely monitor the quality, safety, and reliability of our generic medicines.

Related Articles

Real People

One Pediatric Gastroenterologist’s Mission to Expand Pediatric Treatment Options

Dr. Nicole Kulisek shares her path from pediatric gastroenterologist to US Medical Affairs leader at Pfizer.

Nicole, IBD discussion panel thumbnail

Science & Innovation

How Innovative Diagnostics Are Supporting a Potential Approach to C. difficile

When scientists design a new vaccine candidate, they must also identify diagnostic tests that can be used to measure how effective that vaccine is.

BTS Pearl River colleagues thumbnail

Science & Innovation

Behind the Science: A New Path to Tackling Metastatic Breast Cancer

In recent decades, advances in breast cancer treatment have helped to improve health outcomes for many patients, but scientists remain vigilant in their quest to further reduce both the incidence and impact of the disease.

Jennifer, Pfizer thumbnail

How Drugs Are Made

The medicines available today have taken an average of 12 years to develop. With dedication, creativity, and science, we can significantly cut that time.

Clinical Trials

Learn more about the process of joining a clinical trial and find a trial near you.

Go to Pfizer Clinical Trials Site Details